Ali Tehrani's Insider Trades & SAST Disclosures
Ali Tehrani's most recent trade in Zymeworks BC Inc was a trade of 12,669 Common Shares done at an average price of $36.1 . Disclosure was reported to the exchange on July 12, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ali Tehrani.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.12 per share. | 12 Jul 2021 | 12,669 | 260,325 (0%) | 0% | 36.1 | 457,635 | Common Shares |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 12 Jul 2021 | 12,669 | 272,994 (0%) | 0% | 4.3 | 54,555 | Common Shares |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2021 | 12,669 | 44,991 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 25,000 | 25,000 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 7,708 | 264,717 (0%) | 0% | 0 | Common Shares | |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 7,708 | 15,417 | - | - | Restricted Stock Unit | |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.95 per share. | 10 Mar 2021 | 4,392 | 260,325 (0%) | 0% | 35.0 | 153,516 | Common Shares |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.16 per share. | 07 Dec 2020 | 850 | 55,511 (0%) | 0% | 56.2 | 47,736 | Common Shares |
| Zymeworks BC Inc | Ali Tehrani | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.04 per share. | 02 Nov 2020 | 3,500 | 56,361 (0%) | 0% | 39.0 | 136,624 | Common Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges